Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
979
datasets available to search
ShareScore release 0.9.0
Dataset results
979 results for “HR”
The Moderating Effect of Employee Agility on the Link between Employee Vitality, Digital Literacy and Transformational Leadership with Job Performance: An Empirical Study of HR Practitioners in the Manufacturing Sector of Northern Malaysia.
<p>This is a dataset for a study that examines the effects of employee vitality, digital literacy, and transformational leadership on job performance. Additionally, it investigates the moderating role of employee agility in these relationships. Data were collected from HR practitioners in manufacturing companies in the northern region of Malaysia for analysis. The results indicate that the job performance of HR practitioners is positively influenced by employee vitality, digital literacy and transformational leadership. </p>
Patient Characteristics, Treatment Patterns, and Clinical Outcomes in Patients Diagnosed With HR+/HER2 Advanced/Metastatic Breast Cancer on Palbociclib + Aromatase Inhibitor (AI) Combination Therapy
ClinicalTrials.gov study NCT04394247. IPD Sharing: NO. Countries: 1. Publications: 1.
Palbociclib / Letrozole or Fulvestrant in African American Women With HR+ HER2- Breast Cancer
ClinicalTrials.gov study NCT02692755. IPD Sharing: NO. Countries: 1. Publications: 28.
A Study of Abemaciclib (LY2835219) in Women With HR+, HER2+ Locally Advanced or Metastatic Breast Cancer
ClinicalTrials.gov study NCT02675231. IPD Sharing: YES. Countries: 14. Publications: 2.
Palbociclib Plus Letrozole For Postmenopausal Women With HR(+) HER2(-) Advanced Breast Cancer For Whom Letrozole Is Deemed Appropriate
ClinicalTrials.gov study NCT02600923. IPD Sharing: YES. Countries: 4. Publications: 1.
Use of Sentinel Lymph Node Biopsy in Patients With Early-Stage, Palpable Node-Positive HR+/HER2- Breast Cancer Having Upfront Surgery and Adjuvant Radiation
ClinicalTrials.gov study NCT04854005. IPD Sharing: YES. Countries: 1. Publications: 0.
Phase 3 Trial of Blinatumomab vs Standard Chemotherapy in Pediatric Subjects With HIgh-Risk (HR) First Relapse B-precursor Acute Lymphoblastic Leukemia (ALL)
ClinicalTrials.gov study NCT02393859. IPD Sharing: YES. Countries: 24. Publications: 3.
Study to Evaluate Overall Survival in Japanese Patients With HR+/HER2- Advanced Breast Cancer Treated With Palbociclib Plus Letrozole
ClinicalTrials.gov study NCT04735367. IPD Sharing: NO. Countries: 1. Publications: 2.
Study of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Participants With HR+/HER2- Metastatic Breast Cancer
ClinicalTrials.gov study NCT03901339. IPD Sharing: YES. Countries: 9. Publications: 8.
Trial Evaluating Dovitinib Combined With Fulvestrant, in Postmenopausal Patients With HER2- and HR+ Breast Cancer
ClinicalTrials.gov study NCT01528345. IPD Sharing: Not stated. Countries: 15. Publications: 1.
Study to Evaluate Patient Reported Outcome (PRO) and Physical Activity in Japanese Patients With HR+/HER2- Advanced Breast Cancer Treated With Palbociclib Plus Endocrine Therapy or Endocrine Monothera
ClinicalTrials.gov study NCT04736576. IPD Sharing: NO. Countries: 1. Publications: 1.
Intravesical GEM/DOCE for HR BCG-Unresponsive NMIBC
ClinicalTrials.gov study NCT07322263. IPD Sharing: NO. Countries: 1. Publications: 26.
Study of Efficacy and Safety of Tisagenlecleucel in HR B-ALL EOC MRD Positive Patients
ClinicalTrials.gov study NCT03876769. IPD Sharing: YES. Countries: 11. Publications: 1.
Phase III Palbociclib With Endocrine Therapy vs. Capecitabine in HR+/HER2- MBC With Resistance to Aromatase Inhibitors
ClinicalTrials.gov study NCT02028507. IPD Sharing: NO. Countries: 4. Publications: 4.
A Dose Escalation/Expansion Study of Oral OP-1250 in Subjects With Advanced and/or Metastatic HR+, HER2- Breast Cancer
ClinicalTrials.gov study NCT04505826. IPD Sharing: NO. Countries: 2. Publications: 1.
A Phase-3, Open-Label, Randomized Study of Dato-DXd Versus Investigator's Choice of Chemotherapy (ICC) in Participants With Inoperable or Metastatic HR-Positive, HER2-Negative Breast Cancer Who Have B
ClinicalTrials.gov study NCT05104866. IPD Sharing: YES. Countries: 20. Publications: 2.
Ph II Study of Pembrolizumab & Eribulin in Patients With HR+/HER2- MBC Previously Treated With Anthracyclines & Taxanes
ClinicalTrials.gov study NCT03222856. IPD Sharing: NO. Countries: 1. Publications: 1.
A Study of HR+/HER2- Metastatic Breast Cancer Patients Treated With Palbociclib Together With an Aromatase Inhibitor From 2017 to 2023 in Denmark.
ClinicalTrials.gov study NCT06307457. IPD Sharing: NO. Countries: 1. Publications: 1.
The Study Will Evaluate Average 24-hr Sodium Excretion During Dapagliflozin Treatment in Patients With Type 2 Diabetes Mellitus With Preserved or Impaired Renal Function or Non-diabetics With Impaired
ClinicalTrials.gov study NCT03152084. IPD Sharing: YES. Countries: 2. Publications: 2.
Capivasertib+Fulvestrant vs Placebo+Fulvestrant as Treatment for Locally Advanced (Inoperable) or Metastatic HR+/HER2- Breast Cancer
ClinicalTrials.gov study NCT04305496. IPD Sharing: YES. Countries: 19. Publications: 4.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.